PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,414 | -21.8% | 31,405 | -0.7% | 0.00% | – |
| Q2 2023 | $414,643 | +92.5% | 31,628 | +64.1% | 0.00% | – |
| Q1 2023 | $215,451 | +113.4% | 19,271 | +60.9% | 0.00% | – |
| Q4 2022 | $100,975 | -50.7% | 11,978 | -2.6% | 0.00% | – |
| Q3 2022 | $205,000 | -14.2% | 12,300 | -24.2% | 0.00% | – |
| Q2 2022 | $239,000 | +28.5% | 16,229 | +116.1% | 0.00% | – |
| Q1 2022 | $186,000 | -22.5% | 7,509 | +0.1% | 0.00% | – |
| Q4 2021 | $240,000 | -10.4% | 7,504 | +0.4% | 0.00% | – |
| Q3 2021 | $268,000 | +61.4% | 7,475 | +98.1% | 0.00% | – |
| Q2 2021 | $166,000 | +147.8% | 3,773 | +158.1% | 0.00% | – |
| Q1 2021 | $67,000 | -36.2% | 1,462 | -4.4% | 0.00% | – |
| Q4 2020 | $105,000 | – | 1,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |